GAM
BSX icon

Gould Asset Management’s Boston Scientific BSX Stock Holding History

Gould Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$634K Buy
10,100
+100
+1% +$8K 0.11% 92
2025
Q4 		$954K Sell
10,000
-200
-2% -$19.6K 0.17% 68
2025
Q3 		$996K Hold
10,200
– – 0.18% 66
2025
Q2 		$1.1M Buy
+10,200
New +$1.03M 0.21% 55

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Gould Asset Management's BSX Position: Q1 2026 in Review

Gould Asset Management increased its Boston Scientific (BSX) stake by 1% in Q1 2026, buying an estimated $8K and bringing the position to 10,100 shares worth $634K. The position accounts for 0.11% of the portfolio, ranked #92.

Gould Asset Management first reported a position in BSX in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.1M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Gould Asset Management held 10,100 shares of Boston Scientific worth $634K as of Q1 2026.
  • Gould Asset Management bought 100 Boston Scientific shares in Q1 2026, an estimated $8K.
  • Boston Scientific made up 0.11% of Gould Asset Management's portfolio in Q1 2026, its #92 holding.
  • Gould Asset Management first reported a position in Boston Scientific in Q2 2025 and has held it in 4 quarters since.
  • Gould Asset Management's Boston Scientific position peaked at $1.1M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Gould Asset Management's 13F filing for Q1 2026, filed 6 May 2026.